USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $1.77, $0.04 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $240.4 million versus the consensus estimate of $244.05 million.

Number of active Associates increased by 16.2% to 437,000.

USANA Health Sciences reaffirmed FY2016 guidance.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.